Banco Santander Brasil SA (NYSE:BSBR) Short Interest Update

by · The Cerbat Gem

Banco Santander Brasil SA (NYSE:BSBRGet Free Report) saw a large growth in short interest in December. As of December 15th, there was short interest totaling 2,141,662 shares, a growth of 34.9% from the November 30th total of 1,587,030 shares. Based on an average daily volume of 648,457 shares, the short-interest ratio is currently 3.3 days. Approximately 0.1% of the company’s shares are short sold. Approximately 0.1% of the company’s shares are short sold. Based on an average daily volume of 648,457 shares, the short-interest ratio is currently 3.3 days.

Banco Santander Brasil Stock Performance

Shares of NYSE:BSBR traded down $0.06 on Wednesday, reaching $6.11. The company had a trading volume of 359,620 shares, compared to its average volume of 549,820. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 3.13. Banco Santander Brasil has a 52-week low of $3.75 and a 52-week high of $6.59. The firm’s 50 day simple moving average is $6.05 and its 200-day simple moving average is $5.50.

Banco Santander Brasil Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Thursday, October 23rd were given a dividend of $0.0983 per share. The ex-dividend date of this dividend was Thursday, October 23rd. This is a positive change from Banco Santander Brasil’s previous quarterly dividend of $0.07. This represents a $0.39 annualized dividend and a dividend yield of 6.4%.

Analyst Ratings Changes

Several research firms recently issued reports on BSBR. Weiss Ratings restated a “buy (b-)” rating on shares of Banco Santander Brasil in a research report on Monday. Wall Street Zen upgraded shares of Banco Santander Brasil from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 8th. Finally, The Goldman Sachs Group downgraded Banco Santander Brasil from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 14th. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $4.70.

Get Our Latest Report on BSBR

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of BSBR. Hantz Financial Services Inc. raised its stake in shares of Banco Santander Brasil by 553.9% in the second quarter. Hantz Financial Services Inc. now owns 6,997 shares of the bank’s stock worth $38,000 after purchasing an additional 5,927 shares during the last quarter. Cubist Systematic Strategies LLC acquired a new position in Banco Santander Brasil in the 1st quarter worth approximately $46,000. Vident Advisory LLC acquired a new position in Banco Santander Brasil in the 1st quarter worth approximately $50,000. Public Employees Retirement System of Ohio raised its position in Banco Santander Brasil by 48.9% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 11,617 shares of the bank’s stock worth $63,000 after buying an additional 3,813 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Banco Santander Brasil during the 2nd quarter valued at approximately $70,000. Hedge funds and other institutional investors own 14.53% of the company’s stock.

About Banco Santander Brasil

(Get Free Report)

Banco Santander Brasil SA is the Brazilian unit of Spain-based Grupo Santander and one of the country’s major commercial banks. Headquartered in São Paulo, the bank serves a broad client base across Brazil through an integrated network of branches, ATMs and digital channels. Its shares are represented abroad via American Depositary Shares listed on the New York Stock Exchange under the ticker BSBR.

The bank offers a full range of financial products and services for retail, small and medium-sized enterprises, and corporate clients.

Featured Stories